Cargando…
Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact
INTRODUCTION: Staphylococcus aureus (S. aureus) causes a variety of infections, ranging from a mild skin infection to blood stream infections and deep seated infections. As Stapylococcus aureus bacteremia (SAB) has the tendency to cause endovascular and metastatic infections, complications can occur...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557147/ https://www.ncbi.nlm.nih.gov/pubmed/26392716 http://dx.doi.org/10.4103/0974-777X.162234 |
_version_ | 1782388462751580160 |
---|---|
author | Deodhar, Divya Varghese, George Balaji, Veeraraghavan John, James Rebekah, Grace Janardhanan, Jeshina Jeyaraman, Ranjith Jasmine, Sudha Mathews, Prasad |
author_facet | Deodhar, Divya Varghese, George Balaji, Veeraraghavan John, James Rebekah, Grace Janardhanan, Jeshina Jeyaraman, Ranjith Jasmine, Sudha Mathews, Prasad |
author_sort | Deodhar, Divya |
collection | PubMed |
description | INTRODUCTION: Staphylococcus aureus (S. aureus) causes a variety of infections, ranging from a mild skin infection to blood stream infections and deep seated infections. As Stapylococcus aureus bacteremia (SAB) has the tendency to cause endovascular and metastatic infections, complications can occur at almost all sites of the body. Hence, SAB is associated with increased morbidity and mortality in spite of appropriate antimicrobial treatment. The virulence in S. aureus is determined by the presence of adhesins and toxins, which behave like superantigens (SAgs) and leads to a massive release of proinflammatory cytokines causing overwhelming inflammatory response leading to endothelial leakage, hemodynamic shock, multiorgan failure, and possibly death. MATERIALS AND METHODS: One year prospective study conducted in a tertiary care hospital in southern part of India included all patients with SAB. Clinical details were filled according to. All isolates were subjected to polymerase chain reaction (PCR) for enterotoxin profiling. RESULTS: A total of 101 patients of SAB were identified which comprises of 61 (60.4%) patients with methicillin-susceptible S. aureus (MSSA) and 40 (39.6%) patients with methicillin-resistant S. aureus (MRSA). Most common predictors of mortality were prior hospitalization and antibiotic intake, severe organ dysfunction, shock, tachycardia, and leukocytosis. Two-third of the isolates had at least one enterotoxin, most prevalent was sea; 28% and 27% (P - value = 0.001) MSSA isolates had seg and sei; whereas, 38.6% (P - value < 0.001) of MRSA isolates were found to have sea. The most common enterotoxin associated with mortality was sei, which comprised of 38% of all mortality. CONCLUSION: In SAB, the significant predictors of mortality were prior hospitalization and antibiotic intake, presence of multiorgan dysfunction, and shock. Although overall significance between the enterotoxin and shock could not be demonstrated, it successfully demonstrated the difference of enterotoxin between MSSA and MRSA. |
format | Online Article Text |
id | pubmed-4557147 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45571472015-09-21 Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact Deodhar, Divya Varghese, George Balaji, Veeraraghavan John, James Rebekah, Grace Janardhanan, Jeshina Jeyaraman, Ranjith Jasmine, Sudha Mathews, Prasad J Glob Infect Dis Original Article INTRODUCTION: Staphylococcus aureus (S. aureus) causes a variety of infections, ranging from a mild skin infection to blood stream infections and deep seated infections. As Stapylococcus aureus bacteremia (SAB) has the tendency to cause endovascular and metastatic infections, complications can occur at almost all sites of the body. Hence, SAB is associated with increased morbidity and mortality in spite of appropriate antimicrobial treatment. The virulence in S. aureus is determined by the presence of adhesins and toxins, which behave like superantigens (SAgs) and leads to a massive release of proinflammatory cytokines causing overwhelming inflammatory response leading to endothelial leakage, hemodynamic shock, multiorgan failure, and possibly death. MATERIALS AND METHODS: One year prospective study conducted in a tertiary care hospital in southern part of India included all patients with SAB. Clinical details were filled according to. All isolates were subjected to polymerase chain reaction (PCR) for enterotoxin profiling. RESULTS: A total of 101 patients of SAB were identified which comprises of 61 (60.4%) patients with methicillin-susceptible S. aureus (MSSA) and 40 (39.6%) patients with methicillin-resistant S. aureus (MRSA). Most common predictors of mortality were prior hospitalization and antibiotic intake, severe organ dysfunction, shock, tachycardia, and leukocytosis. Two-third of the isolates had at least one enterotoxin, most prevalent was sea; 28% and 27% (P - value = 0.001) MSSA isolates had seg and sei; whereas, 38.6% (P - value < 0.001) of MRSA isolates were found to have sea. The most common enterotoxin associated with mortality was sei, which comprised of 38% of all mortality. CONCLUSION: In SAB, the significant predictors of mortality were prior hospitalization and antibiotic intake, presence of multiorgan dysfunction, and shock. Although overall significance between the enterotoxin and shock could not be demonstrated, it successfully demonstrated the difference of enterotoxin between MSSA and MRSA. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4557147/ /pubmed/26392716 http://dx.doi.org/10.4103/0974-777X.162234 Text en Copyright: © Journal of Global Infectious Diseases http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Deodhar, Divya Varghese, George Balaji, Veeraraghavan John, James Rebekah, Grace Janardhanan, Jeshina Jeyaraman, Ranjith Jasmine, Sudha Mathews, Prasad Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact |
title | Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact |
title_full | Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact |
title_fullStr | Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact |
title_full_unstemmed | Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact |
title_short | Prevalence of Toxin Genes among the Clinical Isolates of Staphylococcus aureus and its Clinical Impact |
title_sort | prevalence of toxin genes among the clinical isolates of staphylococcus aureus and its clinical impact |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557147/ https://www.ncbi.nlm.nih.gov/pubmed/26392716 http://dx.doi.org/10.4103/0974-777X.162234 |
work_keys_str_mv | AT deodhardivya prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact AT varghesegeorge prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact AT balajiveeraraghavan prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact AT johnjames prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact AT rebekahgrace prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact AT janardhananjeshina prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact AT jeyaramanranjith prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact AT jasminesudha prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact AT mathewsprasad prevalenceoftoxingenesamongtheclinicalisolatesofstaphylococcusaureusanditsclinicalimpact |